Shanghai HeartCare Medical Technology Corporation Limited

Shanghai HeartCare Medical Technology Corporation Limited is a Chinese medical device innovator founded in 2016, specializing in neurointerventional solutions for acute ischemic stroke treatment and prevention. Headquartered in Shanghai Lingang New Area with R&D centers in Nanjing and California, the company has developed a comprehensive portfolio addressing unmet clinical needs in stroke management. The product pipeline includes thrombectomy systems, aneurysm and stenosis treatment devices, interventional access catheters, and stroke prevention instruments. With 34 registered medical device products, over 280 authorized patents, and presence in over 2,500 terminal hospitals across mainland China (excluding Macau), HeartCare is positioned as a pioneer in innovative interventional devices. The company holds Hong Kong listing status (stock code: 06609.HK) and maintains distribution channels covering all provincial administrative regions.